Dare Bioscience, Inc. (DARE) Financial Statements (2024 and earlier)

Company Profile

Business Address 3655 NOBEL DRIVE
SAN DIEGO, CA 92122
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments34,67051,6744,6694,7806,8067,560
Cash and cash equivalents34,67051,6744,6694,7806,8067,560
Receivables1,7031,14546055531284
Prepaid expense6,6662,4771,8541,109403312
Other current assets     193
Total current assets:43,03955,2966,9846,4447,2408,349
Noncurrent Assets
Property, plant and equipment652638649 
Intangible assets, net (including goodwill)      5,188
Goodwill      5,188
Deposits noncurrent assets      
Other noncurrent assets723485529935578723
Total noncurrent assets:7885115679995875,911
TOTAL ASSETS:43,82655,8077,5517,4437,82714,260
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:10,8943,1363,3602,099631967
Employee-related liabilities1,5331,157715416316
Accounts payable2,028    308
Accrued liabilities10,894    342
Other undisclosed accounts payable and accrued liabilities (2,028)1,6032,2031,383215 
Deferred revenue    
Debt   367411  
Business combination, contingent consideration, liability   1,000   
Other undisclosed current liabilities20,73012,9172,9343,103460 
Total current liabilities:31,62416,0537,6615,6121,091967
Noncurrent Liabilities
Liabilities, other than long-term debt1,0901,0001,0421,390100
Deferred revenue and credits0
Deferred revenue1,0001,0001,000 
Deferred rent credit     10
Other liabilities   42390  
Operating lease, liability 90   
Business combination, contingent consideration, liability    1,000  
Total noncurrent liabilities:1,0901,0001,0421,390100
Total liabilities:32,71417,0538,7027,0021,101967
Equity
Equity, attributable to parent11,11238,754(1,152)4416,72713,293
Common stock884211
Additional paid in capital152,530149,02870,36644,56535,79225,541
Accumulated other comprehensive loss(351)(155)(91)(103)(97)(18)
Accumulated deficit(141,075)(110,127)(71,431)(44,023)(28,970)(12,231)
Total equity:11,11238,754(1,152)4416,72713,293
TOTAL LIABILITIES AND EQUITY:43,82655,8077,5517,4437,82714,260

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues10,000     
Gross profit:10,000     
Operating expenses(41,385)(39,069)(27,402)(14,345)(16,882)(11,180)
Operating loss:(31,385)(39,069)(27,402)(14,345)(16,882)(11,180)
Nonoperating income
(Other Nonoperating income)
4383281143 
Interest and debt expense  370   (323)
Other undisclosed loss from continuing operations before equity method investments, income taxes   (0)(0)(75)(18)
Loss from continuing operations before equity method investments, income taxes:(30,948)(38,696)(27,401)(14,264)(16,814)(11,521)
Other undisclosed income (loss) from continuing operations before income taxes(0)0    
Loss from continuing operations before income taxes:(30,948)(38,696)(27,401)(14,264)(16,814)(11,521)
Income tax expense     (3) 
Loss from continuing operations:(30,948)(38,696)(27,401)(14,264)(16,817)(11,521)
Loss before gain (loss) on sale of properties:(38,696)(27,401)(14,264)(16,817)(11,521)
Net loss:(30,948)(38,696)(27,401)(14,264)(16,817)(11,521)
Other undisclosed net income (loss) attributable to parent0(0)007818
Net loss attributable to parent:(30,948)(38,696)(27,401)(14,264)(16,739)(11,503)
Preferred stock dividends and other adjustments   (7)(790)  
Net loss available to common stockholders, diluted:(30,948)(38,696)(27,408)(15,053)(16,739)(11,503)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(30,948)(38,696)(27,401)(14,264)(16,817)(11,521)
Comprehensive loss:(30,948)(38,696)(27,401)(14,264)(16,817)(11,521)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(196)(64)5(795)(0)(0)
Comprehensive loss, net of tax, attributable to parent:(31,144)(38,760)(27,396)(15,059)(16,817)(11,521)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: